Spiral Therapeutics Inc
Pharmaceuticals · SOUTH SAN FRANCISCO, CA
PharmaceuticalsSEC Form D
Spiral Therapeutics Inc filed a Form D with the U.S. Securities and Exchange Commission on April 16, 2026, reporting $27,089,839 raised toward a $27,089,842 offering.
Incorporated in Delaware and based in SOUTH SAN FRANCISCO, CA, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Spiral Therapeutics Inc has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- HUGO PERISExecutive Officer · Director
- ANTHONY ADAMISDirector
- EUGENE DE JUANExecutive Officer · Director
- GUY JEAN SAVOIR GARCIADirector
- ANGELA MACFARLANEDirector
- FREDERIC GUERARDDirector
- DIAMANTIS XYLASDirector
- JEAN-FREDERIC PAULSENDirector
- WARREN THALERDirector
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$50.0KRaised
Matthias Therapeutics, LLC
$5.3MRaised
GridAI Technologies Corp.
$2.5MRaised
GridAI Technologies Corp.
$22.5MRaised
CNS Pharmaceuticals, Inc.
$4.9MRaised